Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls
Article first published online: 30 APR 2001
Copyright © 2001 Wiley-Liss, Inc.
American Journal of Medical Genetics
Volume 105, Issue 4, pages 332–342, 8 May 2001
How to Cite
Perry, R. T., Collins, J. S., Harrell, L. E., Acton, R. T. and Go, R. C.P. (2001), Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am. J. Med. Genet., 105: 332–342. doi: 10.1002/ajmg.1371
- Issue published online: 23 OCT 2002
- Article first published online: 30 APR 2001
- Manuscript Accepted: 13 FEB 2001
- Manuscript Received: 3 OCT 2000
- The NIMH. Grant Number: R01MH60001
- NIA. Grant Number: R01Ag09029
Alzheimer disease (AD) is an emotionally devastating and exceptionally costly disease. Apolipoprotein E (APOE) is a major risk factor gene for AD regardless of age of onset or family history. However, this association may not be as strong or consistent in ethnic groups such as African Americans, raising the possibility of other modifier gene(s). In a group of African American AD patients, a significantly increased risk of AD was associated with two E4 alleles (OR = 5.6; 95% CI = 1.5–21.0) or one E4 allele (OR = 2.5; 95% CI = 1.3–5.0) when compared to E3/E3 genotype, and there was a significant lowering of age of onset for affecteds with E4/E4 genotype as compared to one E2 allele (P = 0.02) or all others (P = 0.03). We also found a significant increase in age of onset with the −308 #2 (A) allele of TNF when compared to AD cases with no #2 allele. A significant increase in age was also demonstrated with the #2 allele (99 base pairs) of the microsatellite TNFa, located ∼ 10.5 kb upstream of TNF. When these two alleles were combined with the TNF −238G (#1) allele to give a haplotype, the significant increase in age was still demonstrated. Polymorphisms in the APOE promoter and six other candidate genes did not appear to demonstrate any significant association with our African American AD patients. Our results confirm the established association of APOE4 to AD observed in several ethnic groups, including African Americans. In addition, TNF appears to have some modifying effect in AD, primarily on age of onset, or it could be in linkage disequilibrium with a modifier locus nearby. © 2001 Wiley-Liss, Inc.